SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Financial Adviser to Redmile Group LLC (“Redmile”), in respect of its recommended Mandatory Cash Offer for the entire issued and to be issued ordinary share capital of AIM quoted Redx Pharma plc (“Redx”) that were not already held or agreed to be acquired by Redmile which valued Redx at £29.45 million.
The Offer closed successfully on 30 April 2020.
Redmile is an employee owned hedge fund sponsor, the firm primarily provides its services to pooled investment vehicles and the firm invests in public equity markets worldwide. Redmile was founded in March 2007 and is based in San Francisco, California.
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom.